A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience

Yazar
Mueller-Ohldach, Mathis
Kramer, Alwin
Scarato, Jeremy
Thomas, Marlene
Moch, Holger
Pauli, Chantal
Bochtler, Tilmann
Mileshkin, Linda
Baciarello, Giulia
Losa, Ferran
Ross, Jeffrey S.
Pentheroudakis, George
Zarkavelis, George
YALÇIN, ŞUAYİB
ÖZGÜROĞLU, Mustafa
Beringer, Andreas
Üst veri
Tüm öğe kaydını göster
Özet
Background CUPISCO is an ongoing randomized phase II trial (NCT03498521) comparing molecularly guided therapy versus platinum-based chemotherapy in patients newly diagnosed with "unfavorable" cancer of unknown primary (CUP).
Bağlantı
http://hdl.handle.net/20.500.12627/168139
https://doi.org/10.1002/onco.13744
Koleksiyonlar